MEP54208A - Medicaments containing steroids and a novel anticholinesterase drug - Google Patents
Medicaments containing steroids and a novel anticholinesterase drugInfo
- Publication number
- MEP54208A MEP54208A MEP-542/08A MEP54208A MEP54208A ME P54208 A MEP54208 A ME P54208A ME P54208 A MEP54208 A ME P54208A ME P54208 A MEP54208 A ME P54208A
- Authority
- ME
- Montenegro
- Prior art keywords
- medicaments containing
- containing steroids
- novel
- anticholinesterase drug
- novel anticholinesterase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10216429A DE10216429A1 (de) | 2002-04-12 | 2002-04-12 | Arzneimittel enthaltend Steroide und ein neues Anticholinergikum |
| YUP-899/04A RS50776B (sr) | 2002-04-12 | 2003-04-09 | Medikamenti koji sadrže steroide i novi lek antiholinesteraze |
| PCT/EP2003/003668 WO2003086399A1 (de) | 2002-04-12 | 2003-04-09 | Arzneimittel enthaltend steroide und ein neues anticholinergikum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP54208A true MEP54208A (en) | 2011-05-10 |
Family
ID=28458802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-542/08A MEP54208A (en) | 2002-04-12 | 2003-04-09 | Medicaments containing steroids and a novel anticholinesterase drug |
Country Status (29)
| Country | Link |
|---|---|
| EP (2) | EP1496902B1 (sr) |
| JP (1) | JP4559086B2 (sr) |
| KR (1) | KR101010869B1 (sr) |
| CN (1) | CN1646126A (sr) |
| AR (1) | AR039275A1 (sr) |
| AT (1) | ATE312607T1 (sr) |
| AU (1) | AU2003216921B2 (sr) |
| BR (1) | BR0309085A (sr) |
| CA (1) | CA2481268C (sr) |
| DE (2) | DE10216429A1 (sr) |
| DK (1) | DK1496902T3 (sr) |
| EA (1) | EA008386B1 (sr) |
| EC (1) | ECSP045355A (sr) |
| ES (1) | ES2254917T3 (sr) |
| HR (1) | HRP20040943B1 (sr) |
| IL (2) | IL164391A0 (sr) |
| ME (1) | MEP54208A (sr) |
| MX (1) | MXPA04009917A (sr) |
| MY (1) | MY137045A (sr) |
| NO (1) | NO20044097L (sr) |
| NZ (1) | NZ536284A (sr) |
| PE (1) | PE20040326A1 (sr) |
| PL (1) | PL211227B1 (sr) |
| RS (1) | RS50776B (sr) |
| TW (1) | TWI311055B (sr) |
| UA (1) | UA80125C2 (sr) |
| UY (1) | UY27758A1 (sr) |
| WO (1) | WO2003086399A1 (sr) |
| ZA (1) | ZA200406751B (sr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| BR0209271A (pt) | 2001-04-30 | 2004-06-15 | Glaxo Group Ltd | Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| PL1713473T3 (pl) * | 2004-02-06 | 2013-08-30 | Meda Pharma Gmbh & Co Kg | Kombinacja leków antycholinergicznych i glikokortykoidów do długotrwałego leczenia astmy i POChP |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| EP3111926B1 (en) | 2009-05-29 | 2019-12-11 | Pearl Therapeutics, Inc. | Compositions, methods & systems for respiratory delivery of two or more active agents |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| RU2696582C2 (ru) | 2013-03-15 | 2019-08-05 | Перл Терапьютикс, Инк. | Способы и системы кондиционирования дисперсных кристаллических материалов |
| CN115282411A (zh) * | 2022-01-14 | 2022-11-04 | 温州医科大学 | 利用鼻嗅区递送药物入脑的输送系统及其应用方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
| US4811731A (en) | 1985-07-30 | 1989-03-14 | Glaxo Group Limited | Devices for administering medicaments to patients |
| SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
| DE4108393A1 (de) | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln |
| IL107120A (en) | 1992-09-29 | 1997-09-30 | Boehringer Ingelheim Int | Atomising nozzle and filter and spray generating device |
| DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
| US5750540A (en) * | 1995-04-28 | 1998-05-12 | Banyu Pharmaceutical Co., Ltd. | 1,4-di-substituted piperidine derivatives |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| DE19536903C2 (de) | 1995-10-04 | 1998-09-10 | Boehringer Ingelheim Int | Vorrichtung zum Haltern eines fluidischen Bauteils |
| DE19545226C1 (de) | 1995-12-05 | 1997-06-19 | Boehringer Ingelheim Int | Sperrspannwerk für einen federbetätigten Abtrieb |
| GB0009591D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medical combinations |
| DE10050994A1 (de) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
| JP2004512359A (ja) * | 2000-10-31 | 2004-04-22 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 抗コリン作用薬及びコルチコステロイドをベースとする新規医薬組成物 |
-
2002
- 2002-04-12 DE DE10216429A patent/DE10216429A1/de not_active Withdrawn
-
2003
- 2003-04-09 EP EP03712137A patent/EP1496902B1/de not_active Expired - Lifetime
- 2003-04-09 EP EP05109887A patent/EP1621197A3/de not_active Withdrawn
- 2003-04-09 DE DE50301934T patent/DE50301934D1/de not_active Expired - Lifetime
- 2003-04-09 JP JP2003583418A patent/JP4559086B2/ja not_active Expired - Lifetime
- 2003-04-09 HR HRP20040943AA patent/HRP20040943B1/hr not_active IP Right Cessation
- 2003-04-09 KR KR1020047016335A patent/KR101010869B1/ko not_active Expired - Fee Related
- 2003-04-09 AR ARP030101241A patent/AR039275A1/es unknown
- 2003-04-09 AT AT03712137T patent/ATE312607T1/de active
- 2003-04-09 DK DK03712137T patent/DK1496902T3/da active
- 2003-04-09 NZ NZ536284A patent/NZ536284A/en not_active IP Right Cessation
- 2003-04-09 BR BR0309085-0A patent/BR0309085A/pt not_active IP Right Cessation
- 2003-04-09 IL IL16439103A patent/IL164391A0/xx unknown
- 2003-04-09 EA EA200401303A patent/EA008386B1/ru not_active IP Right Cessation
- 2003-04-09 ES ES03712137T patent/ES2254917T3/es not_active Expired - Lifetime
- 2003-04-09 CN CNA038083299A patent/CN1646126A/zh active Pending
- 2003-04-09 MX MXPA04009917A patent/MXPA04009917A/es active IP Right Grant
- 2003-04-09 ME MEP-542/08A patent/MEP54208A/xx unknown
- 2003-04-09 PL PL371561A patent/PL211227B1/pl not_active IP Right Cessation
- 2003-04-09 CA CA2481268A patent/CA2481268C/en not_active Expired - Lifetime
- 2003-04-09 RS YUP-899/04A patent/RS50776B/sr unknown
- 2003-04-09 WO PCT/EP2003/003668 patent/WO2003086399A1/de not_active Ceased
- 2003-04-09 AU AU2003216921A patent/AU2003216921B2/en not_active Expired
- 2003-04-10 UY UY27758A patent/UY27758A1/es not_active Application Discontinuation
- 2003-04-10 TW TW092108227A patent/TWI311055B/zh not_active IP Right Cessation
- 2003-04-10 PE PE2003000365A patent/PE20040326A1/es not_active Application Discontinuation
- 2003-04-10 MY MYPI20031320A patent/MY137045A/en unknown
- 2003-09-04 UA UA20041109192A patent/UA80125C2/uk unknown
-
2004
- 2004-08-25 ZA ZA200406751A patent/ZA200406751B/en unknown
- 2004-09-27 NO NO20044097A patent/NO20044097L/no not_active Application Discontinuation
- 2004-10-04 IL IL164391A patent/IL164391A/en not_active IP Right Cessation
- 2004-10-11 EC EC2004005355A patent/ECSP045355A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP36608A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
| BR0308937A (pt) | Compostos imidazo fundidos | |
| YU35503A (sh) | Nove kompozicije lekova bazirane na solima tiotropijuma i solima salmeterola | |
| MEP54208A (en) | Medicaments containing steroids and a novel anticholinesterase drug | |
| UY26992A1 (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinérgicos y corticoesteroides | |
| MEP10408A (en) | Platinum derivative pharmaceutical formulations | |
| EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| YU2003A (sh) | Stabilne soli o-acetilsalicilne kiseline sa baznim amino-kiselinama | |
| BR0309185A (pt) | Medicamento contendo beta-miméticos e um novo anticolinérgico | |
| TW200607799A (en) | Therapeutic compounds: pyridine as scaffold | |
| BRPI0608178A2 (pt) | derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos | |
| UY27759A1 (es) | Combinaciones de medicamentos que contienen compuestos heterocíclicos y un nuevo agente anticolinérgico. | |
| HRP20041092B1 (hr) | Novi farmaceutski pripravci flibanserina | |
| BR0210912A (pt) | Compostos e composições como inibidores de catepsina | |
| EA200600854A1 (ru) | Новые соли тиотропия, способ их получения, а также содержащие их лекарственные композиции | |
| BRPI0408689B8 (pt) | derivados de benzenosulfonamida, método para preparação e utilização disso para o tratamento da dor | |
| BR0314261A (pt) | Compostos, processo de preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de um composto, método para tratamento e/ou profilaxia de enfermidades e utilização e/ou método de tratamento | |
| BRPI0513287A (pt) | derivados de pirido-pirimidina, sua preparação, sua aplicação em terapêutica | |
| MEP51308A (en) | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same | |
| BR0307703A (pt) | Composições de medicamentos na base de agentes anticolinérgicos e inibidores de quinase de egfr | |
| BR0312507A (pt) | Composições de medicamentos à base de novos anticolinérgicos e inibidores de egfr-cinase | |
| BRPI0506702A (pt) | composto, uso do mesmo, composição farmacêutica, método para a terapia de dor, e de distúrbios gatrointestinais funcionais em um animal de sangue quente, e, processo para preparar um composto | |
| ATE452639T1 (de) | Arzneimittelkompositionen aus tiotropiumsalzen und epinastin zur therapie von atemswegserkrankungen | |
| MEP39708A (en) | New pharmaceutical compositions containing epinastine and pseudoephedrine | |
| EA200401302A1 (ru) | Лекарственные средства, содержащие бетамиметики и новое антихолинергическое средство |